Tectonic Therapeutic | AVRO - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
Celltrion KRW 11.84B 1.34B 2026-03
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 11.8B 2.17B 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
Ionis Pharmaceuticals USD -114M 21M 2026-06
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
MacroGenics USD -36.77M 21.84M 2026-03
Medical Developments International AUD -149K 466K 2025-06
Neuren Pharmaceuticals AUD 19.21M 9.35M 2025-12
Organigram Holdings CAD -921K 40.8M 2026-03
Pfizer USD -653M 5.84B 2026-06
Pharma Mar EUR -993K 2.59M 2026-06
Qiagen NV USD 85.83M 23.34M 2026-03
Roche Holding CHF 11.17B 6.38B 2026-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR 837M 1.17B 2026-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Sartorius EUR 127M 30.8M 2026-06
Takeda JPY 162.72B 215.2B 2026-06
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -394M 12.5M 2026-03
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03